Name Development Level Target Family
Glutathione reductase, mitochondrial Tclin Enzyme
Name Description
carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
TCRDv4.6.0
DrugCentral Indication
DrugCentral
carmustine